RT Journal Article
SR Electronic
T1 Multi-organ imaging-derived polygenic indexes for brain and body health
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.18.23288769
DO 10.1101/2023.04.18.23288769
A1 Yang, Xiaochen
A1 Sullivan, Patrick F.
A1 Li, Bingxuan
A1 Fan, Zirui
A1 Ding, Dezheng
A1 Shu, Juan
A1 Guo, Yuxin
A1 Paschou, Peristera
A1 Bao, Jingxuan
A1 Shen, Li
A1 Ritchie, Marylyn D.
A1 Nave, Gideon
A1 Platt, Michael L.
A1 Li, Tengfei
A1 Zhu, Hongtu
A1 Zhao, Bingxin
YR 2024
UL http://medrxiv.org/content/early/2024/06/03/2023.04.18.23288769.abstract
AB The UK Biobank (UKB) imaging project is a crucial resource for biomedical research, but is limited to 100,000 participants due to cost and accessibility barriers. Here we used genetic data to predict heritable imaging-derived phenotypes (IDPs) for a larger cohort. We developed and evaluated 4,375 IDP genetic scores (IGS) derived from UKB brain and body images. When applied to UKB participants who were not imaged, IGS revealed links to numerous phenotypes and stratified participants at increased risk for both brain and somatic diseases. For example, IGS identified individuals at higher risk for Alzheimer’s disease and multiple sclerosis, offering additional insights beyond traditional polygenic risk scores of these diseases. When applied to independent external cohorts, IGS also stratified those at high disease risk in the All of Us Research Program and the Alzheimer’s Disease Neuroimaging Initiative study. Our results demonstrate that, while the UKB imaging cohort is largely healthy and may not be the most enriched for disease risk management, it holds immense potential for stratifying the risk of various brain and body diseases in broader external genetic cohorts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number RF1AG082938. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study has also been partially supported by funding from the Wharton Dean's Research Fund, Analytics at Wharton, and Purdue Statistics Department.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The individual-level data used in the present study have been openly available from the UK Biobank (https://www.ukbiobank.ac.uk/) study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes